All Type of News
Pharmacists to seek cap on credit card fee
The Korea Pharmaceutical Association said it will have a meeting with government officials over fees credit card firms charge pharmacies, demanding more fee slash in consideration of pharmacy's better management.
P...
Yungjin ties with Kaneka on coenzyme Q10Yungjin Pharm said on September 6 that it has joined with Japanese chemical and resin maker Kaneka Corp. to import the latter's coenzyme Q10 that is becoming increasingly popula...
|
Dong-A unveils new medication for periodonal diseaseDong-A Pharm said it has launched Depasa for the prevention and treatment of gum disease.
Depasa is available as capsules containing lysozyme HCl, tocopherol acetate and asco...
|
First prescription omega-3 product offers proven benefitKuhnil Pharm's Omacor, an omega-3-acid ethyl esters product approved by the Korea Food and Drug Administration in May 2006, has captured a sizable market volume with an expected...
|
Novartis, Pfizer to co-market Exforge in October
Novartis Korea and Pfizer Korea said on September 6 that they will begin the co-marketing of Exforge, a combined formulation of amlodipine, a dihydropyridine calcium-channel blocker, and valsartan, an angiotensin II r...
GSK presents clinical trial results at 12th World Conference on Lung Cancer
GlaxoSmithKline presented results from their clinical results of new medicines at the 12th World Conference on Lung Cancer being held in Seoul, Korea September 2-6, 2007.
The data presented at this symposium by wor...
Wholesalers ready for self-reform
The Korea Association of Drug Wholesalers plans to encourage its member wholesalers to voluntarily make changes through strict application of the law to root out some irregular business practices such as back margins....
Iressa is comparable to docetaxel in survival rate
AstraZeneca Korea said on September 5 that patients with non-small cell lung cancer (NSCLC) treated with the oral anti-cancer drug Iressa (gefitinib) in the INTEREST study had equivalent (non-inferior) survival to tho...
TDS PALM acquires NES certification for hydrogel wound dressing technology
TDS PALM, a local biopharmaceutical company, said that it has won a New Excellent Technology (NES) certification for locally invented hydrogel wound dressing.
The hydrogel dressing made with TDS's new technology is...
20 Merck executives to visit Korea
Some 20 executives of the U.S. pharmaceutical firm Merck & Co. are scheduled to visit Seoul to attend Bio Korea 2007 in Seoul, Korea from September 1214, 2007 at COEX.
Bio Korea 2007 will feature high-level confere...
